Conventional manufacturing of dosage forms for small molecule drugs in centralized facilities is not well-suited to meet the needs of adaptive clinical trials for early-phase dose escalation and ...

SUZHOU, China, Nov. 13, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that a clinical trial (Study ID: JSKN033-102) of JSKN033, a high-concentration subcutaneous ...

Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced ...

Study 06CCL3-001 is a multi-centre, randomized, double-blind, parallel-arm study that will compare the efficacy and safety of Labopharm's twice-daily tramadol-acetaminophen combination product to ...

Event Overview: Formulation Development is a key element in the pharmaceutical development process. There is an increasing trend by companies to outsource not just this service, but an integrated ...

Grand Cayman, Cayman Islands, April 23, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA ...

Hyderabad, India: Asia's leading Discovery Research and Development organization, GVK BIO, announced the extended collaboration with Melbourne, Australia based clinical stage biopharmaceutical company ...

The availability of a choice of the 1- and 3M depot formulations provides more individualized, patient-orientated treatment. The 3M depot coincides with regular oncological patient checkup visits of 3 ...

As efforts to develop an effective vaccine for COVID-19 continue, in parallel, drug developers are investigating the effectiveness of existing drugs at treating patients with COVID-19. The ...

The oral probiotic supplement industry is experiencing a fundamental transformation in 2025, as consumers increasingly demand ingredient transparency and clinical research backing over marketing ...

As efforts to develop an effective vaccine for COVID-19 continue, in parallel, drug developers are investigating the effectiveness of existing drugs at treating patients with COVID-19. The ...